A study done by researchers from the University of Utah Health Care shows usage of insulin in type 2 diabetes (T2D) patients to the increased risk of the development of end-stage renal disease (ESRD - a kidney disease). Previous studies linked insulin usage to the increased risk of the development of atherosclerosis. Researchers studied more than 188,000 individuals with type 2 diabetes (T2D). Researchers analyzed several factors
Researchers surprised after above analysis that among diabetes individuals using insulin medication, the HbA1c range is not predictive of ESRD incidences. They stressed the relationship between insulin usage in type 2 diabetes individuals and risk of the development of ESRD. This study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases. Lead author of the study is Srinivasan Beddhu, MD.
Diabetes disrupts blood circulation in the body by damaging blood vessels and veins. Blood vessels supply blood (with glucose and oxygen) to cells of the body organs and parts such as limbs, heart, kidneys, eyes and brain. Diabetes reduces blood circulation in arteries, narrow blood vessels and veins. Reduction in blood circulation in narrow blood vessels prevents wound healing process. When free flow of blood is affected, the body will face major problems such as amputations, heart diseases, kidney failure and blindness. Individuals are at risk of the development of ulcers, bunions and cracked skin in the feet and legs. Antibiotics may not help diabetes patients in preventing serious (advanced) infections such as gangrene. Blood circulation in damaged legs can be restored by using patient's own vein to bypass blood with a procedure known as revascularization. But restoring blood circulation in lower limbs will be difficult. Diabetes individual must follow a proper diet and daily exercise program to reduce serious complications of diabetes.
Pebble company was sold to Fitbit (owners of Flex 2 and Charge 2). Existing Pebble wearable device users may not receive software updates. As per the deal, Fitbit owns all intellectual property rights of Pebble's software, development and other assets. Pebble company existing products and software are not being affected but the company no longer makes new devices and products. Pebble products under development such as Time 2, Core and Time Round products were suspended and the company is going to refund backers. Pebble is going to use its wearables expertise to the future development of Fitbit wearable devices and products.
A recent study projected 74 million elderly individuals in the United States by the year 2030. There is a need for affordable health care solutions in the form of wearable technology devices for elderly people as they are facing health and economic struggles such as vision, hearing, communication & memory loss and difficulty in moving. Now major wearable technology companies are focusing on helping elder individuals by manufacturing smart wearable products. Some of them under development are
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.